Introduction
The clinical performance of new implants, which are marketed with insufficient documentation, is often unsatisfactory. Boneloc R cement was marketed without any clinical documentation. We began using it for routine total hip replacements (THR) in February 1992 because there was promise of it being less toxic [6, 12, 15] , it would be easier to handle, polymer leakage into the air was reduced because of an integrated mixing system [2, 7, 12] , and it had a lower polymerisation temperature than our usual cement (Palacos R ) [12] .
After one year, the frequency of loosening was so high that we discontinued Boneloc R and began using Palacos R again.
This paper presents the results of a clinical and radiographic follow up at 2 years of all the patients who had a THR in this period and to report our experience with Boneloc R cement after observation from 24 to 39 months.
Patients and methods
Between February 1992 and April 1993, 147 THRs were performed in the Orthopaedic Department of Svenborg Hospital. Charnley components were used in every case with either a lateral (Charnley), anterolateral (Hardinge) or posterior (Moore) approach. The femoral canal was blocked with a polyethylene plug. The cement was inserted with a cement gun and then pressurised.
The Boneloc R cement (Polymers Reconstructive A/S, Farum, Denmark -distributed by Biomet Denmark A/S) was used for uncomplicated cases. Palacos R with gentamicin (Shering-Plough Inc, Farum, Denmark) was used for cases where there was an increased risk of infection such as failed primary arthroplasties, previous operations on the hip, rheumatoid arthritis and patients treated with steroids.
Both types of cement were mixed according to the manufacturer's instructions and the composition of each is shown in Table 1 .
The number of patients, their diagnosis, age and sex are shown in Tables 2 and 3. The preoperative function was evaluated using Merle d'Aubigne and Postel's method [3] . This was repeated at the 2 year follow up. Radiographs were taken after 2 weeks, 3 months, 6 months and 2 years.
The distribution of cement around the femoral stem was analysed in the radiographs by Gruen et al's modification [5] of Kristiansen and Jensen's method [8] . DeLee and Charnley's method was used for the acetabular socket [4] . The femoral stem was divided into 5 and the socket into 3 zones. The packing of the cement was defined as adequate if the thickness of the cement mantle was at least 2 mm in more than half of the zones (Fig. 1) .
Radiographs at the 2 year follow up were evaluated, and the stability of the implants was classified into 3 categories: (1) definitely loose radiographically: there was migration of 2 mm or more, a radiolucent zone of more than 2 mm in 3 of 5 zones around the stem and in 2 of 3 zones around the socket, or if there were any cement fractures; (2) not loose: there was no migration and no radiolucent area of more than 2 mm in 2 of 5 zones around the stem and in one of 3 zones around the socket. (3) possibly loose: anything in between (1) and (2) [8, 9] .
Results
Eight patients died during the follow up without known prosthetic loosening, 7 with Boneloc R and 88 N. Wedderkopp et al.: Aseptic loosening of cemented hip prostheses " one with Palacos R . One patient with Boneloc R was lost to follow up because of chronic heart disease. The number of loose prostheses is shown in Table 4 . Radiographic cement fractures were found in 8 of the loose prostheses.
During follow up (0 to 24 months), 9 patients had their prostheses revised, with the stem only involved. Clinical failure was defined as radiographic loosening and pain leading to revision. At the end of the period of observation (24 to 39 months), clinical failure had occurred in 26 patients in the Boneloc R group. Nineteen were revised; further operation was contraindicated because of medical conditions in 2; one had died; one was waiting for revision, and 3 had not yet accepted reoperation. Prosthesis survival in the Boneloc R group is shown by a Kaplan-Meier plot (Fig. 2 ). There were no clinical failures in the Palacos R group.
The distribution of the cement was analysed according to Kristansen and Jensen [8] and found to be good in all the implants, except for one in the Boneloc R group, but this patient had no signs of loosening.
In the Boneloc R group, 2 femoral stems were positioned in 5°to 10°of varus. In the Palacos R group, 4 femoral stems were in 5°to 10°of varus; none were in greater varus than this and none were in valgus. The malpositioned prostheses showed no signs of loosening.
The preoperative function index was 9.1 (range 4 to 15) in the Palacos R group and 9.8 (range 6 to 15) in the Boneloc R . At 2 years, the index was 15.4 in both groups (Palacos R 10 to 18; Boneloc R 7 to 18). Eighteen patients in the Boneloc R group regularly experienced pain, and 12 used paracetamol or nonsteroidal anti-inflammatory drugs. In the Palacos R group, 2 had pain regularly and also used weak analgesics.
Thirteen patients in the Boneloc R group were dissatisfied with their results at follow-up. They reported that their symptoms had become worse since their last routine examination 6 months after the operation. Two in the Palacos R group were dissatisfied, but their symptoms had not become worse since their last examination.
There was no difference in the frequency of loosening when the different operative techniques were compared.
Discussion
Boneloc R cement was introduced because of several theoretical and practical advantages. It was less toxic [6, 15] , easier to handle with less polymer leakage into air because of the integrated mixing and application system [2] . The polymerisation temperature was lower and there was a lower concentration of methylmethacrylate in venous blood. Residual amines in the cement had been reduced [6] .
In spite of these theoretical advantages, earlier studies had shown unacceptably high rates of loosening [11, 13, 14] which were confirmed in our study. Loosening might follow poor cementing technique, with inadequate filling of cavities or malposition of the femoral stem, but we have shown that this was not the explanation in our cases.
Thanner et al compared Palacos R and Boneloc R and confirmed the finding of a lower concentration of methylmethacrylate in venous blood, but if all types of monomers were considered the release from Boneloc R was greater than from Palacos R [16] . They also showed that tensile strength and elastic modulus were less in Boneloc R compared to Palacos R , and that it provided less good fixation of both acetabular and femoral components [16] . In our cases, the stem tended to loosen, and at revision we found fragmentation of the cement and poor fixation to bone. The reason could be the low glass transition temperature of Boneloc R allowing migration of residual monomers at 37°C which possibly create increased radiolucent lines and less good fixation [16] .
We also noticed unpredictable behaviour of Boneloc R , often with a very short setting time which made it difficult to insert the components. Nevertheless, Riegels-Nielsen et al did not find cement fractures in the trochanteric region [13] .
Thanner et al. also described stem migration inside the cement mantle, especially with Boneloc R , and suggested this might be due to increased elasticity and inferior in vitro fatigue properties [16] which could explain the cement fractures in our study.
More than half of our cases cemented with Palacos R with gentamicin were done for the primary treatment of fractures of the femoral neck, for the sequelae of childhood diseases and the failure of primary THRs (Table 2) , and a higher rate of loosening might have been expected. On the contrary, the risk of loosening in the Boneloc R group was 8 times greater than with Palacos R . Table 4 shows that the number of possible loose prostheses in the Boneloc R group suggesting that revision will be needed in the future.
We recommend that Boneloc R cement should not be used. Patients who have a THR with this type of cement should be told about the risk of loosening and offered further follow-up.
